位置:首页 > 蛋白库 > SBP1_HUMAN
SBP1_HUMAN
ID   SBP1_HUMAN              Reviewed;         472 AA.
AC   Q13228; A6NML9; A6PVW9; B2RDR3; B4DKP6; B4E1F3; Q49AQ8; Q96GX7;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   29-MAY-2007, sequence version 2.
DT   03-AUG-2022, entry version 179.
DE   RecName: Full=Methanethiol oxidase {ECO:0000303|PubMed:29255262};
DE            Short=MTO {ECO:0000303|PubMed:29255262};
DE            EC=1.8.3.4 {ECO:0000269|PubMed:29255262};
DE   AltName: Full=56 kDa selenium-binding protein;
DE            Short=SBP56;
DE            Short=SP56;
DE   AltName: Full=Selenium-binding protein 1;
GN   Name=SELENBP1; Synonyms=SBP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=9027582;
RX   DOI=10.1002/(sici)1097-4644(199702)64:2<217::aid-jcb5>3.0.co;2-#;
RA   Chang P.W.G., Tsui S.K.W., Liew C., Lee C., Waye M.M.Y., Fung K.;
RT   "Isolation, characterization, and chromosomal mapping of a novel cDNA clone
RT   encoding human selenium binding protein.";
RL   J. Cell. Biochem. 64:217-224(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4).
RC   TISSUE=Colon, Lung, and Synovial cell;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Colon, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 255-276, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Vishwanath V.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [8]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=9679983;
RA   Yang M., Sytkowski A.J.;
RT   "Differential expression and androgen regulation of the human selenium-
RT   binding protein gene hSP56 in prostate cancer cells.";
RL   Cancer Res. 58:3150-3153(1998).
RN   [9]
RP   TISSUE SPECIFICITY, SUBCELLULAR LOCATION, PHOSPHORYLATION, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=14991897; DOI=10.1002/path.1524;
RA   Chen G., Wang H., Miller C.T., Thomas D.G., Gharib T.G., Misek D.E.,
RA   Giordano T.J., Orringer M.B., Hanash S.M., Beer D.G.;
RT   "Reduced selenium-binding protein 1 expression is associated with poor
RT   outcome in lung adenocarcinomas.";
RL   J. Pathol. 202:321-329(2004).
RN   [10]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=16223876; DOI=10.1073/pnas.0507666102;
RA   Glatt S.J., Everall I.P., Kremen W.S., Corbeil J., Sasik R., Khanlou N.,
RA   Han M., Liew C.-C., Tsuang M.T.;
RT   "Comparative gene expression analysis of blood and brain provides
RT   concurrent validation of SELENBP1 up-regulation in schizophrenia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:15533-15538(2005).
RN   [11]
RP   TISSUE SPECIFICITY, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16380993; DOI=10.1002/ijc.21671;
RA   Huang K.-C., Park D.C., Ng S.-K., Lee J.Y., Ni X., Ng W.-C., Bandera C.A.,
RA   Welch W.R., Berkowitz R.S., Mok S.C., Ng S.-W.;
RT   "Selenium binding protein 1 in ovarian cancer.";
RL   Int. J. Cancer 118:2433-2440(2006).
RN   [12]
RP   TISSUE SPECIFICITY, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16645984; DOI=10.1002/pmic.200500629;
RA   Kim H., Kang H.J., You K.T., Kim S.H., Lee K.Y., Kim T.I., Kim C.,
RA   Song S.Y., Kim H.-J., Lee C., Kim H.;
RT   "Suppression of human selenium-binding protein 1 is a late event in
RT   colorectal carcinogenesis and is associated with poor survival.";
RL   Proteomics 6:3466-3476(2006).
RN   [13]
RP   INTERACTION WITH USP33.
RX   PubMed=19118533; DOI=10.1016/j.bbrc.2008.12.110;
RA   Jeong J.Y., Wang Y., Sytkowski A.J.;
RT   "Human selenium binding protein-1 (hSP56) interacts with VDU1 in a
RT   selenium-dependent manner.";
RL   Biochem. Biophys. Res. Commun. 379:583-588(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-111 AND SER-371, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, TISSUE SPECIFICITY, INVOLVEMENT IN
RP   EHMTO, VARIANTS EHMTO TRP-225; TYR-329 AND 347-GLY--ILE-472 DEL,
RP   CHARACTERIZATION OF VARIANTS EHMTO TRP-225; TYR-329 AND 347-GLY--ILE-472
RP   DEL, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=29255262; DOI=10.1038/s41588-017-0006-7;
RA   Pol A., Renkema G.H., Tangerman A., Winkel E.G., Engelke U.F.,
RA   de Brouwer A.P.M., Lloyd K.C., Araiza R.S., van den Heuvel L., Omran H.,
RA   Olbrich H., Oude Elberink M., Gilissen C., Rodenburg R.J., Sass J.O.,
RA   Schwab K.O., Schaefer H., Venselaar H., Sequeira J.S., Op den Camp H.J.M.,
RA   Wevers R.A.;
RT   "Mutations in SELENBP1, encoding a novel human methanethiol oxidase, cause
RT   extraoral halitosis.";
RL   Nat. Genet. 50:120-129(2018).
CC   -!- FUNCTION: Catalyzes the oxidation of methanethiol, an organosulfur
CC       compound known to be produced in substantial amounts by gut bacteria
CC       (PubMed:29255262). Selenium-binding protein which may be involved in
CC       the sensing of reactive xenobiotics in the cytoplasm. May be involved
CC       in intra-Golgi protein transport (By similarity).
CC       {ECO:0000250|UniProtKB:Q8VIF7, ECO:0000269|PubMed:29255262}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + methanethiol + O2 = formaldehyde + H(+) + H2O2 +
CC         hydrogen sulfide; Xref=Rhea:RHEA:11812, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:16007,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:16842, ChEBI:CHEBI:29919; EC=1.8.3.4;
CC         Evidence={ECO:0000269|PubMed:29255262};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4.8 nM for methanethiol {ECO:0000269|PubMed:29255262};
CC   -!- PATHWAY: Organosulfur degradation. {ECO:0000269|PubMed:29255262}.
CC   -!- SUBUNIT: Interacts with USP33. {ECO:0000269|PubMed:19118533}.
CC   -!- INTERACTION:
CC       Q13228; Q9UJ68: MSRA; NbExp=3; IntAct=EBI-711619, EBI-19157918;
CC       Q13228; O43422: THAP12; NbExp=3; IntAct=EBI-711619, EBI-2828217;
CC       Q13228; Q15645: TRIP13; NbExp=6; IntAct=EBI-711619, EBI-358993;
CC       Q13228; Q8TEY7-2: USP33; NbExp=5; IntAct=EBI-711619, EBI-719307;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14991897}. Cytoplasm,
CC       cytosol {ECO:0000269|PubMed:14991897, ECO:0000269|PubMed:16223876}.
CC       Membrane {ECO:0000250|UniProtKB:Q8VIF7}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q8VIF7}. Note=May associate with Golgi membrane
CC       (By similarity). May associate with the membrane of autophagosomes (By
CC       similarity). {ECO:0000250|UniProtKB:Q8VIF7}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q13228-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13228-2; Sequence=VSP_038440;
CC       Name=3;
CC         IsoId=Q13228-3; Sequence=VSP_045425;
CC       Name=4;
CC         IsoId=Q13228-4; Sequence=VSP_055126;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in liver, lung,
CC       colon, prostate, kidney and pancreas. In brain, present both in neurons
CC       and glia (at protein level). Down-regulated in lung adenocarcinoma,
CC       colorectal carcinoma and ovarian cancer. Two-fold up-regulated in brain
CC       and blood from schizophrenia patients. {ECO:0000269|PubMed:14991897,
CC       ECO:0000269|PubMed:16223876, ECO:0000269|PubMed:16380993,
CC       ECO:0000269|PubMed:16645984, ECO:0000269|PubMed:29255262,
CC       ECO:0000269|PubMed:9679983}.
CC   -!- INDUCTION: Down-regulated by androgen in prostate cancer cells.
CC       {ECO:0000269|PubMed:9679983}.
CC   -!- PTM: Phosphorylated. {ECO:0000305|PubMed:14991897}.
CC   -!- PTM: The N-terminus is blocked. {ECO:0000250}.
CC   -!- DISEASE: Extraoral halitosis due to methanethiol oxidase deficiency
CC       (EHMTO) [MIM:618148]: An autosomal recessive malodor condition
CC       characterized by extraoral blood-borne halitosis resulting from the
CC       accumulation of sulfur-containing metabolites. In extraoral blood-borne
CC       halitosis, malodorant compounds are carried to the lungs, where they
CC       enter the breath. Affected individuals have a cabbage-like breath odor,
CC       high levels of methanethiol and dimethylsulfide in oral and nasal
CC       breath, and elevated urinary excretion of dimethylsulfoxide in the
CC       absence of intake of dimethylsulfide-containing food or use of sulfur-
CC       containing medication, lower-gastrointestinal problems, and known
CC       metabolic defects, such as methionine adenosyltransferase deficiency
CC       and tyrosinemia. {ECO:0000269|PubMed:29255262}. Note=The disease is
CC       caused by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the selenium-binding protein family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U29091; AAB02395.1; -; mRNA.
DR   EMBL; CR456852; CAG33133.1; -; mRNA.
DR   EMBL; AK296661; BAG59258.1; -; mRNA.
DR   EMBL; AK303815; BAG64765.1; -; mRNA.
DR   EMBL; AK315643; BAG38010.1; -; mRNA.
DR   EMBL; AL391069; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW53443.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53445.1; -; Genomic_DNA.
DR   EMBL; BC009084; AAH09084.1; -; mRNA.
DR   EMBL; BC032997; AAH32997.1; -; mRNA.
DR   CCDS; CCDS58027.1; -. [Q13228-3]
DR   CCDS; CCDS60266.1; -. [Q13228-4]
DR   CCDS; CCDS995.1; -. [Q13228-1]
DR   PIR; G01872; G01872.
DR   RefSeq; NP_001245217.1; NM_001258288.1. [Q13228-3]
DR   RefSeq; NP_001245218.1; NM_001258289.1. [Q13228-4]
DR   RefSeq; NP_003935.2; NM_003944.3. [Q13228-1]
DR   AlphaFoldDB; Q13228; -.
DR   SMR; Q13228; -.
DR   BioGRID; 114472; 187.
DR   CORUM; Q13228; -.
DR   IntAct; Q13228; 44.
DR   MINT; Q13228; -.
DR   STRING; 9606.ENSP00000397261; -.
DR   GlyGen; Q13228; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q13228; -.
DR   PhosphoSitePlus; Q13228; -.
DR   SwissPalm; Q13228; -.
DR   BioMuta; SELENBP1; -.
DR   DMDM; 148840437; -.
DR   REPRODUCTION-2DPAGE; IPI00012303; -.
DR   REPRODUCTION-2DPAGE; Q13228; -.
DR   UCD-2DPAGE; Q13228; -.
DR   EPD; Q13228; -.
DR   jPOST; Q13228; -.
DR   MassIVE; Q13228; -.
DR   MaxQB; Q13228; -.
DR   PaxDb; Q13228; -.
DR   PeptideAtlas; Q13228; -.
DR   PRIDE; Q13228; -.
DR   ProteomicsDB; 1722; -.
DR   ProteomicsDB; 5753; -.
DR   ProteomicsDB; 59234; -. [Q13228-1]
DR   ProteomicsDB; 59235; -. [Q13228-2]
DR   Antibodypedia; 1584; 391 antibodies from 30 providers.
DR   DNASU; 8991; -.
DR   Ensembl; ENST00000368868.10; ENSP00000357861.5; ENSG00000143416.21. [Q13228-1]
DR   Ensembl; ENST00000426705.6; ENSP00000397261.2; ENSG00000143416.21. [Q13228-4]
DR   Ensembl; ENST00000447402.7; ENSP00000413960.3; ENSG00000143416.21. [Q13228-3]
DR   GeneID; 8991; -.
DR   KEGG; hsa:8991; -.
DR   MANE-Select; ENST00000368868.10; ENSP00000357861.5; NM_003944.4; NP_003935.2.
DR   UCSC; uc010pcy.4; human. [Q13228-1]
DR   CTD; 8991; -.
DR   DisGeNET; 8991; -.
DR   GeneCards; SELENBP1; -.
DR   HGNC; HGNC:10719; SELENBP1.
DR   HPA; ENSG00000143416; Tissue enhanced (intestine).
DR   MalaCards; SELENBP1; -.
DR   MIM; 604188; gene.
DR   MIM; 618148; phenotype.
DR   neXtProt; NX_Q13228; -.
DR   OpenTargets; ENSG00000143416; -.
DR   Orphanet; 562538; Autosomal recessive extra-oral halitosis.
DR   PharmGKB; PA35641; -.
DR   VEuPathDB; HostDB:ENSG00000143416; -.
DR   eggNOG; KOG0918; Eukaryota.
DR   GeneTree; ENSGT00390000014244; -.
DR   HOGENOM; CLU_032512_0_0_1; -.
DR   InParanoid; Q13228; -.
DR   OMA; FDSEFNC; -.
DR   OrthoDB; 483905at2759; -.
DR   PhylomeDB; Q13228; -.
DR   TreeFam; TF315241; -.
DR   PathwayCommons; Q13228; -.
DR   SignaLink; Q13228; -.
DR   BioGRID-ORCS; 8991; 17 hits in 1086 CRISPR screens.
DR   ChiTaRS; SELENBP1; human.
DR   GeneWiki; SELENBP1; -.
DR   GenomeRNAi; 8991; -.
DR   Pharos; Q13228; Tbio.
DR   PRO; PR:Q13228; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q13228; protein.
DR   Bgee; ENSG00000143416; Expressed in mucosa of transverse colon and 200 other tissues.
DR   ExpressionAtlas; Q13228; baseline and differential.
DR   Genevisible; Q13228; HS.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0018549; F:methanethiol oxidase activity; IMP:FlyBase.
DR   GO; GO:0008430; F:selenium binding; TAS:ProtInc.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   InterPro; IPR008826; Se-bd.
DR   PANTHER; PTHR23300; PTHR23300; 1.
DR   Pfam; PF05694; SBP56; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cytoplasm; Direct protein sequencing;
KW   Disease variant; Membrane; Nucleus; Oxidoreductase; Phosphoprotein;
KW   Protein transport; Reference proteome; Selenium; Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   CHAIN           2..472
FT                   /note="Methanethiol oxidase"
FT                   /id="PRO_0000174633"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         111
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         371
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         467
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P17563"
FT   VAR_SEQ         1..64
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_038440"
FT   VAR_SEQ         1
FT                   /note="M -> MRLEWGPRPAALPWPAGMCAAERAEGAFTLQSVAQPMRPIAST (in
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055126"
FT   VAR_SEQ         59..120
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045425"
FT   VARIANT         225
FT                   /note="G -> W (in EHMTO; loss of methanethiol oxidation in
FT                   patient cells; dbSNP:rs758495626)"
FT                   /evidence="ECO:0000269|PubMed:29255262"
FT                   /id="VAR_080207"
FT   VARIANT         329
FT                   /note="H -> Y (in EHMTO; loss of methanethiol oxidation in
FT                   patient cells; dbSNP:rs1553204840)"
FT                   /evidence="ECO:0000269|PubMed:29255262"
FT                   /id="VAR_080208"
FT   VARIANT         347..472
FT                   /note="Missing (in EHMTO; loss of methanethiol oxidation in
FT                   patient cells)"
FT                   /evidence="ECO:0000269|PubMed:29255262"
FT                   /id="VAR_080209"
FT   CONFLICT        80
FT                   /note="C -> Y (in Ref. 1; AAB02395)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        92
FT                   /note="T -> N (in Ref. 1; AAB02395)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        114..116
FT                   /note="RAP -> GPQ (in Ref. 1; AAB02395)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        135
FT                   /note="F -> C (in Ref. 1; AAB02395)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        260..262
FT                   /note="DAA -> SAT (in Ref. 1; AAB02395)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        270..273
FT                   /note="LSST -> SAPN (in Ref. 1; AAB02395)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        278
FT                   /note="Y -> C (in Ref. 3; BAG59258)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        280..282
FT                   /note="NEG -> TRE (in Ref. 1; AAB02395)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        305..306
FT                   /note="EM -> GV (in Ref. 1; AAB02395)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        410
FT                   /note="D -> E (in Ref. 1; AAB02395)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        442
FT                   /note="F -> C (in Ref. 1; AAB02395)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   472 AA;  52391 MW;  6DC68F9B45FEC1BC CRC64;
     MATKCGNCGP GYSTPLEAMK GPREEIVYLP CIYRNTGTEA PDYLATVDVD PKSPQYCQVI
     HRLPMPNLKD ELHHSGWNTC SSCFGDSTKS RTKLVLPSLI SSRIYVVDVG SEPRAPKLHK
     VIEPKDIHAK CELAFLHTSH CLASGEVMIS SLGDVKGNGK GGFVLLDGET FEVKGTWERP
     GGAAPLGYDF WYQPRHNVMI STEWAAPNVL RDGFNPADVE AGLYGSHLYV WDWQRHEIVQ
     TLSLKDGLIP LEIRFLHNPD AAQGFVGCAL SSTIQRFYKN EGGTWSVEKV IQVPPKKVKG
     WLLPEMPGLI TDILLSLDDR FLYFSNWLHG DLRQYDISDP QRPRLTGQLF LGGSIVKGGP
     VQVLEDEELK SQPEPLVVKG KRVAGGPQMI QLSLDGKRLY ITTSLYSAWD KQFYPDLIRE
     GSVMLQVDVD TVKGGLKLNP NFLVDFGKEP LGPALAHELR YPGGDCSSDI WI
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024